Alexandra Schäfer

2004–2025 年に発表

94
論文数
18,950
被引用数
51
h 指数
88
i10 指数

被引用数

Alexandra Schäfer の年別被引用数1998 年: 被引用 1 件2004 年: 被引用 3 件2005 年: 被引用 27 件2006 年: 被引用 67 件2007 年: 被引用 58 件2008 年: 被引用 59 件2009 年: 被引用 32 件2010 年: 被引用 29 件2011 年: 被引用 21 件2012 年: 被引用 26 件2013 年: 被引用 32 件2014 年: 被引用 28 件2015 年: 被引用 28 件2016 年: 被引用 26 件2017 年: 被引用 29 件2018 年: 被引用 18 件2019 年: 被引用 64 件2020 年: 被引用 1,730 件2021 年: 被引用 2,815 件2022 年: 被引用 1,761 件2023 年: 被引用 816 件2024 年: 被引用 1,005 件2025 年: 被引用 416 件2026 年: 被引用 6 件1999〜2003 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,223 件、この内訳の 29.3%中国: 引用元論文 1,278 件、この内訳の 11.6%イギリス: 引用元論文 601 件、この内訳の 5.5%ドイツ: 引用元論文 450 件、この内訳の 4.1%インド: 引用元論文 426 件、この内訳の 3.9%フランス: 引用元論文 345 件、この内訳の 3.1%カナダ: 引用元論文 336 件、この内訳の 3.1%イタリア: 引用元論文 308 件、この内訳の 2.8%日本: 引用元論文 263 件、この内訳の 2.4%オーストラリア: 引用元論文 258 件、この内訳の 2.3%スイス: 引用元論文 229 件、この内訳の 2.1%オランダ: 引用元論文 201 件、この内訳の 1.8%
0%29.3%その他 28%

分野

  • Medicine75.1%
  • Biochemistry, Genetics and Molecular Biology12%
  • Immunology and Microbiology6.2%
  • Computer Science1.6%
  • Agricultural and Biological Sciences1.2%
  • Neuroscience0.8%
  • その他3.1%

トピック

  • SARS-CoV-2 and COVID-19 Research21.2%
  • COVID-19 Clinical Research Studies12.7%
  • Long-Term Effects of COVID-193.6%
  • Viral gastroenteritis research and epidemiology3.5%
  • Animal Virus Infections Studies3.5%
  • SARS-CoV-2 detection and testing3.1%
  • その他52.4%

共著者

全論文

検索で開く
  1. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emily Phung, Lauren A. Chang, Rebecca J. Loomis, Nedim Emil Altaras, Elisabeth Narayanan, Mihir Metkar, Vladimir Presnyak, Cuiping Liu, Mark K. Louder, Wei Shi, Kwanyee Leung, Eun Sung Yang, Ande West, Kendra L. Gully, Laura J. Stevens, Nianshuang Wang, Daniel Wrapp, Nicole A. Doria‐Rose, Guillaume Stewart-Jones, Hamilton Bennett, Gabriela Alvarado, Martha Nason, Tracy J. Ruckwardt, Jason S. McLellan, Mark R. Denison, James D. Chappell, Ian N. Moore, Kaitlyn M. Morabito, John R. Mascola, Ralph S. Baric, Andrea Carfı́, Barney S. Graham - Nature 2020 被引用: 1,687

  2. SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luther A. Bartelt, Ross E. Zumwalt, Fernando J. Martínez, Steven Salvatore, Alain Borczuk, Purushothama Rao Tata, Vishwaraj Sontake, Adam J. Kimple, Ilona Jaspers, Wanda K. O’Neal, Scott H. Randell, Richard C. Boucher, Ralph S. Baric - Cell 2020 被引用: 1,676

  3. A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice

    著者: , , , , , , , , , , , , , , , , , , - Cell 2020 被引用: 683

  4. A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Diamond - Cell 2020 被引用: 635

  5. Potently neutralizing and protective human antibodies against SARS-CoV-2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicole L. Kallewaard, Broc T. McCune, Shamus P. Keeler, Michael J. Holtzman, Dan H. Barouch, Lisa E. Gralinski, Ralph S. Baric, Larissa B. Thackray, Michael Diamond, Robert H. Carnahan, James E. Crowe - Nature 2020 被引用: 1,201

  6. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas B. Lewis, Miklós Guttman, Helen Y. Chu, Kelly K. Lee, Deborah H. Fuller, Ralph S. Baric, Paul Kellam, Lauren Carter, Marion Pepper, Timothy P. Sheahan, David Veesler, Neil P. King - Cell 2020 被引用: 590

  7. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2020 被引用: 1,165

  8. A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

    著者: , , , , , , , , , , , , , , , , , , - Nature 2020 被引用: 689

  9. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Science 2020 被引用: 1,003

  10. Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis R. Burton, Raiees Andrabi - Immunity 2023 被引用: 167

  11. SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa M. Barton, Eric J. Duval, Sanjay Mukhopadhyay, Edana Stroberg, Alain Borczuk, Leigh B. Thorne, Muthu Sakthivel, Yueh Z. Lee, James S. Hagood, Jason R. Mock, Max A. Seibold, Wanda K. O’Neal, Stephanie A. Montgomery, Richard C. Boucher, Ralph S. Baric - Science Translational Medicine 2022 被引用: 120

  12. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah R. Leist, David R. Martinez, Matthew Clark, Roland Tisch, Derek T. O’Hagan, Robbert van der Most, Wesley C. Van Voorhis, Davide Corti, Jason S. McLellan, Harry Kleanthous, Timothy P. Sheahan, Kelly D. Smith, Deborah H. Fuller, François Villinger, Jesse D. Bloom, Bali Pulendran, Ralph S. Baric, Neil P. King, David Veesler - Cell 2021 被引用: 192

  13. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura L. Sutherland, David C. Montefiori, Robert J. Edwards, Kevin O. Saunders, Charlene McDanal, Giovanna E. Hernandez, Katayoun Mansouri, Robert E. Parks, Xiaozhi Lu, Blake M. Hauser, C. Todd DeMarco, Fangping Cai, Barney S. Graham, Kevin Wiehe, John R. Mascola, Gregory D. Sempowski, Hanné Andersen, Elizabeth Petzold, David R. Martinez, Peter D. Kwong, Victoria Gee-Lai, Megan Kopp, S. Gobeil, Victoria Stalls, Aja Sanzone, Wes Rountree, Barton F. Haynes, Mark G. Lewis, Priyamvada Acharya, Thomas H. Oguin, Chuancang Jiang, I‐Ting Teng, Andrew Foulger, Christopher W. Woods - Cell 2021 被引用: 334

  14. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice

    著者: , , , , , , , , , , , , , , , , - Science 2021 被引用: 202

  15. Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2020 被引用: 540

  16. Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy

    著者: , , , , , , , , , , - Nature 2021 被引用: 199

  17. Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alessandra Livraghi-Butrico, Eddie Wehri, Richard R. Behringer, Dong‐Joo Cheon, Julia Schaletzky, Hector C. Aguilar, Andreas S. Puschnik, Brian Button, Benjamin A. Pinsky, Catherine A. Blish, Ralph S. Baric, Wanda K. O’Neal, Carolyn R. Bertozzi, Craig B. Wilen, Richard C. Boucher, Jan E. Carette, Sarah A. Stanley, Eva Harris, Silvana Konermann, Patrick D. Hsu - Nature Genetics 2022 被引用: 144

  18. Stabilized coronavirus spike stem elicits a broadly protective antibody

    著者: , , , , , , , , , , , , , , , , , , , - Cell Reports 2021 被引用: 111

  19. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

    著者: , , , , , , , , , , , , , , , , , , - Nature Communications 2020 被引用: 1,810

  20. Antibody potency, effector function, and combinations in protection and therapy for SARS-CoV-2 infection in vivo

    著者: , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2020 被引用: 357

  21. Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2023 被引用: 50

  22. A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus

    著者: , , , , , , , , , , , , , , , , , - Science Translational Medicine 2023 被引用: 38

  23. Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

    著者: , , , , , , - mBio 2015 被引用: 465

  24. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2021 被引用: 101